(Circulation. 2001;103:296.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
From the Department of Zoology, the George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv (U.O., T.Y., A.O.), and Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa (D.M., R.S., G.H., U.D., L.G., T.W., S.B.H.), Israel, and Department of Experimental Pathology, LH Holland Laboratory of the American Red Cross, Rockville, Md (C.H.).
| Abstract |
|---|
|
|
|---|
Methods and ResultsMyocardial infarction (MI) was induced in 50 dogs and 26 rats by ligation of the left anterior descending coronary artery. After induction of MI, the laser-irradiated (LI) group received laser irradiation (infrared laser, 803-nm wavelength) epicardially. Control MI-induced nonlaser irradiated (NLI) dogs were sham-operated, and laser was not applied. All dogs were euthanized at 5 to 6 weeks after MI. Infarct size was determined by TTC staining and histology. The laser treatment (P<0.05) lowered mortality significantly, from 30% to 6.5%, after induction of MI. The infarct size in the LI dogs was reduced significantly (P<0.0001) (52%) compared with NLI dogs. Histological observation of the infarct revealed a typical scar tissue in NLI dogs and cellularity in most of the LI dogs. Only 14±3% of the mitochondria in the cardiomyocytes in the ischemic zone (4 hours after MI) of LI MI-induced rats were severely damaged, compared with 36±1% in NLI rats. Accordingly, ATP content in that zone was 7.6-fold (significantly) higher in LI than in NLI rats.
ConclusionsOur observations indicate that epicardial LELI of rat and dog hearts after chronic MI caused a marked reduction in infarct size, probably due to a cardioprotective effect of the LELI.
Key Words: ischemia myocardial infarction antioxidants lasers
| Introduction |
|---|
|
|
|---|
Many studies have been directed toward the use of drugs, growth factors, and various interventional technologies in reducing myocardial infarct size and improvement of heart function after MI in experimental animals and humans. For example, recombinant adenovirusmediated transfer of genes encoding antioxidants to the myocardium has been demonstrated to attenuate after ischemic dysfunction in neonatal mice.3 Novel approaches to enhancing angiogenesis in the ischemic myocardium by introducing growth factors (mainly of the vascular endothelial growth factor family) were adapted and found to have a beneficial effect on patients with severe angina.4
Low-energy laser irradiation (LELI) has been found to modulate various biological processes.5 6 7 Laser irradiation, for example, could cause an increase in mitochondrial respiration and ATP synthesis,8 accelerate wound healing, and promote the process of skeletal muscle regeneration after injury.6 9 Inflammatory response after injury was markedly decreased by laser irradiation,9 and neoformation of blood vessels in the injured zone of skeletal muscles was elevated.10 We recently showed that LELI induces synthesis of cell-cycle regulatory proteins in tissue cultures of satellite cells from skeletal muscle because of activation of early cell-cycleregulatory genes.11 The effects of LELI on cardiac cells have been studied to a limited extent. Zhu et al12 recently showed that argon dye laser (660-nm wavelength) improves the functional recovery of cold-stored, isolated rat cardiomyocytes. In the present study, we investigated the possibility that LELI may also attenuate the process of scar tissue formation after chronic occlusion of the LAD in rats and dogs.
| Methods |
|---|
|
|
|---|
15 minutes after MI, and
the second was applied 3 days after MI after thoracotomy, as in the
first irradiation. The control MI-induced NLI dogs were sham-operated
as above, but the laser was not turned on. All dogs were euthanized 5
to 6 weeks after MI except for 2 beagle dogs that were used for
electron microscopy and were euthanized 3 weeks after MI. Control or LI
dogs were randomly selected.
MI in 26 rats (8 to 10 weeks old, 250 to 300 g) was
induced by chronic ligation of the LAD
3 mm distal to where it
branches off the aorta after thoracotomy. Laser irradiation was
performed 10 to 15 minutes after MI through the intercostal muscles at
the same power density (at the level of the myocardium) as in the dogs.
All rats were euthanized 4 hours after MI. Twelve rats (6 LI and 6 NLI)
were used for electron microscopy (see below), and 14 rats (8 LI
and 6 NLI) served for ATP determination. Samples were taken from the
ischemic zone in the left ventricle, homogenized in Tris 0.01 mol/L (pH
7.4)/2 mmol/L CaCl2 buffer, and used for ATP
determination.
Histology and Infarct Size
Determination
The dogs received diazepam before euthanasia with an
intravenous overdose of KCl containing heparin (400 IU/kg). The hearts
were exteriorized and perfused with 500 mL of 2% triphenyltetrazolium
chloride (TTC) solution in saline at 37°C at a flow rate of 50
mL/min. They were then perfused with 4% phosphate-buffered formalin as
above, rinsed in formalin for 48 hours, and then transversely cut into
6-mm slices. Infarct size was determined by scanning of the slices and
use of computerized morphometry software (Sigma Scan Pro 4.0, Jandel
Scientific). The total volume of the infarct in each section was
calculated as the volume of a trapezium with upper and lower bases of
the infarct area in each slice, multiplied by its height. The infarct
size in each dog was defined as the sum of the volumes of all infarcts
in all slices and was expressed as a percentage of the total volume of
the left ventricle. Five to 8 tissue samples bearing the infarcted area
(endocardium to epicardium) were taken from each heart, and sections
were prepared and stained with Massons trichrome to delineate fibrous
tissue and immunohistochemistry.
Immunohistochemistry and Electron
Microscopy
For desmin immunostaining, the peroxidase staining
kit (No. 9543, Zymed Inc) was applied on paraffin serial sections of
formaldehyde-fixed dog heart tissue. Sections were deparaffinized and
hydrated in alcohol and incubated with peroxidase 3% followed by
blocking solution for 15 minutes. The sections were washed with
PBSTween 20 solution and then incubated with mouse antidesmin
(Biomakor) diluted 1:100 for 30 minutes at room temperature.
Biotingoat anti-mouse IgG was then applied for 30 minutes at room
temperature after a washing as above. Horseradish
peroxidasestreptavidin conjugate was then applied for 30 minutes,
followed by incubation with chromogen solution for 10 minutes. Sections
were counterstained with hematoxylin. Quantitative analysis of the
percentage of positive desmin expression structures in the infarcted
area and in the interphase between the infarcted and the noninfarcted
area was determined by computerized morphometry and Sigma Scan Pro
software. Data were statistically analyzed by nested ANOVA as described
previously.9
Twelve rats and 2 dogs (1 LI and 1 NLI) were euthanized 4 hours and 3 weeks after MI, respectively. Random samples from the ischemic area were fixed in 3.5% glutaraldehyde in 0.2 mol/L sodium cacodylate buffer, postfixed in OsO4, and embedded in epoxy resin. Thin sections from 4 different regions (randomly chosen) of each of the above samples (in rats) were cut, and photographs were taken from 6 fixed points (intersections of the grid bars) on each grid. The quantitative morphometric measurements of these photographs were performed by video imaging and Sigma Scan Pro 4.0 Software. The percentage (of total numbers) of damaged mitochondria (>50% elevation of volume relative to normal and cristae and membranes ruptured) was recorded in each micrograph.
Analytical Procedures and Statistics
Blood samples were collected from the leg veins of
each dog daily after MI. The troponin-T level in blood serum at each
time point after MI was determined with the human immunoprecipitation
kit (Boehringer-Mannheim). Troponin-T accumulation in the blood after
MI was calculated from the area under the curve (arbitrary units) of
the troponin-T quantitative data versus time. Catalase in serum was
determined by oxygen electrodes with proper standards. One unit of
catalase was defined as the amount of enzyme that produces 1 µmol of
oxygen per minute. ATP was determined with the luciferin-luciferase
assay kit (Sigma).
The SPSS software was used for statistical analysis. Tests were performed first for normality distribution, followed by parametric (Students t test) or nonparametric (exact Wilcoxon) tests. Fishers exact test (for mortality analysis) was also used.
| Results |
|---|
|
|
|---|
|
|
|
|
The histological characteristics of 5 to 7 regions in the
infarcted zone in each NLI or LI dog were investigated. The
histological sections from NLI dogs showed typical histopathological
features of an infarct of 5 weeks after MI with inactive scar tissue
consisting mostly of dense collagen with sparse and mature fibrocytes
(Figure 5a
). Histological analysis of the LI dogs revealed
infarcts that were distinct from those in the respective NLI dogs in
their large content of viable cells and loose matrix containing sparse
collagen in the form of thin, wavy filaments
(Figure 5b
).
|
Desmin immunostaining was performed on serial sections of
the general histology sections. The relative area occupied by
desmin-expressing structures in the interphase zone (between the
infarcted and the noninfarcted tissue) was significantly
(P<0.01) higher (7.3-fold) in
the LI dogs than in the NLI dogs
(Figure 5c
through 5e). The percentage of these structures
within the infarct composed 8±3% in the LI dogs, compared with
1±0.7% in the NLI dogs. Desmin staining was weak in normal mature
myocardium and confined to Z lines and intercalated disks
(Figure 5f
). Cells that demonstrated a strong positive
homogeneous immunostaining of desmin in their cytoplasm were found
within the infarcted zone of the LI dogs
(Figure 5g
). In more developed cardiomyocytes, usually
organized in bulk in the infarcted area, desmin staining was also
confined to the Z line
(Figure 5h
). Electron microscopic examination revealed cells
in the infarcted area containing clusters of ribosomes and unorganized
myogenic filaments in their cytoplasm, indicating cells that synthesize
myogenic proteins de novo
(Figure 5i
).
At 4 hours after LAD occlusion in rats, the infarcted
areas of NLI and LI rats were analyzed by electron microscopy.
Disorganization of contractile proteins, vacuolization, and
mitochondria with various degrees of distended and ruptured cristae and
clearance of electron-dense matrix characterized the cardiomyocytes in
the infarcted zone in NLI rat hearts
(Figure 6a
). In the LI rat hearts, the cardiomyocytes
manifested minor disorganization of the myofibrillar proteins,
vacuolization in the cytoplasm, and a limited number of damaged
mitochondria
(Figure 6b
). The quantitative morphometric results indicated
that 36.0±0.5% (mean±SD) of the mitochondria in the NLI
cardiomyocytes were severely damaged, compared with only 14.9±2.6%
(P<0.001) in the LI
cardiomyocytes
(Figure 6c
). Accordingly, the content of ATP in the ischemic
zone of the LI rats 4 hours after LAD occlusion was 7.6-fold higher
(P<0.05) than that of the NLI
rats
(Figure 6d
).
|
| Discussion |
|---|
|
|
|---|
60% reduction in the number of damaged mitochondria in the
LI rats compared with NLI rats. These results correlate with the much
higher level of ATP that was found in the ischemic area in the
myocardium of the LELI rats compared with the NLI rats at the same time
interval after LAD occlusion. Thus, it may be postulated that the LELI
given within a short time interval after occlusion of the coronary
arteries may attenuate the irreversible adverse effects that take place
in the cardiomyocyte mitochondria in the ischemic zone and inhibit the
very rapid decrease in ATP. Indeed, LELI has been found to increase
mitochondrial respiration and ATP
synthesis.8 Thus, the injured
laser-irradiated cells may have a much slower rate of degeneration
because of an increase in ATP production in the LI rats. The decrease
in the number of injured cardiomyocytes may also markedly reduce the
inflammatory response after LAD occlusion in the myocardium, as we
previously showed for toad skeletal muscles after
injury.9 This phenomenon may,
in turn, reduce the adverse effects that have been attributed to the
leukocyte infiltration that is part of the complex sequential processes
that occur after
MI.13 The reduction in troponin-T release to blood, as found in the present study during 48 hours after LAD occlusion in the LI dogs compared with NLI dogs, lends further credence to the contribution of LELI to the reduction of cardiomyocyte destruction in the ischemic zone during the initial phase after MI. Myocardial ischemic injury is also mediated, at least in part, by the generation and accumulation of reactive oxygen species in the cells under ischemic conditions, which also take part in their degenerative process. The present study demonstrated that catalase, which is one of the major enzymes in the antioxidative machinery in the cells, was significantly elevated in the serum of the LI dogs 24 hours after LAD occlusion compared with NLI dogs. It can be assumed that this elevation reflects the increase of catalase in the myocardium at a short time interval after MI by LELI, as was previously shown for isolated cardiomyocytes.12 This elevated antioxidant activity in the dog ischemic myocardium is probably one of the mechanisms inhibiting cardiomyocyte degeneration and asserting a cardioprotective effect on these cells in the ischemic zone. The inverse significant correlation between the level of catalase after MI and infarct size in the dogs further supports the assumption that the antioxidant level in the ischemic myocardium at the early phase after LAD occlusion plays a major role in the complex processes that eventually lead to scar formation. Indeed, Woo et al3 demonstrated that induction of antioxidant production via gene transfer to the heart of neonatal mice improved its functional performance. Catalase was also found to increase within the myocardium 24 hours after whole-body heat stress.14 Thus, the possible link between LELI and heat-shock proteins associated with cardioprotection and infarct development15 cannot be ruled out. It may be postulated that LELI stimulated overproduction of heat-shock proteins in cardiomyocytes and thus increased their survival in the ischemic zone after LAD occlusion. Furthermore, it was shown that carvedilol, a potent antioxidant, produces a high degree of cardioprotection in ischemic cardiac injury.16
The histological appearance of the infarcts of the LI dogs was more cellular and less collagenous than that of the NLI dogs. It may be postulated that possibly more presumptive fibroblasts in the infarcted area are transformed into myofibroblasts after LELI. Indeed, Pourreau-Schneider et al,17 using electron microscopic methods and immunohistochemistry, previously showed that a direct and massive transformation of cultured fibroblasts into myofibroblasts was observed in tissue cultures 24 hours after He-Ne laser irradiation, whereas control cultures included only resting and active fibroblasts. Furthermore, we also found, in the present study, that a significantly higher percentage of cells within the infarcted and peri-infarcted zone of the LI dogs react positively to desmin than in the NLI dogs. Desmin was found in the cytoplasm of developing myogenic cells from skeletal muscles18 and is considered to be a marker for myogenic cells. On the basis of the above findings and the electron microscopic observations, one can assume that this phenomenon indicates the ability of the cells within the infarcted zone of the LI dogs and partially injured cardiomyocytes in the peri-infarcted zone to synthesize myogenic contractile proteins de novo.
Because treatment of the chronic complications that arise from the complex processes of cardiac repair after infarct has not yet been resolved,1 the results of the present study may also have clinical relevance. On the basis of our previous results showing that direct LELI on myoblasts in culture does not affect their differentiation in vitro11 and that the use of LELI in humans has no known deleterious effects,5 it can be postulated that the use of LELI after MI is probably safe. Our observations indicate that delivery of laser energy to the heart may have an important beneficial effect on patients after acute MI or other ischemic heart conditions that are not accessible to current revascularization procedures. Because LELI by itself does not destroy any additional precious myocardial tissue, it will be suitable for catheter-based interventions alone or together with diagnostic intraventricular navigation procedures.19 20 21 It can be postulated that LELI can be delivered to the myocardium in humans via fiber optics in the catheter of the nonfluoroscopic in vivo navigation and mapping technology19 currently in use in experimental animals and in humans.20 21 The LELI energy can also be applied during or after the procedure of balloon angiography by use of a catheter with a central canal bearing a fiber optic, through which the laser energy can be delivered transversely (360°) to the infarcted area. Furthermore, as an adjunct procedure to other, increasingly popular approaches for repairing ischemic myocardium (angioplasty, stenting, grafting, transmyocardial revascularization, etc), the cardioprotective effect of LELI may likewise be beneficial at minimal or no additional risk.
In conclusion, to the best of our present knowledge, the results of this study demonstrate for the first time a marked reduction in infarct size by LELI after MI in dogs. Thus, LELI can significantly attenuate the processes that take place after MI in dog myocardium and lead to formation of scar tissue. Because the next frontier in the treatment of ischemic heart disease lies in the development of substances for specifically targeted molecular therapeutics for patients after MI,1 the phenomenon described in the present study may also shed light on the possible nature of such substances.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received May 9, 2000; revision received July 16, 2000; accepted July 28, 2000.
| References |
|---|
|
|
|---|
-sarcomeric
actin and desmin during myogenesis in rat and mouse embryo, I: skeletal
muscle. Differentiation. 1990;44:132142.[Medline]
[Order article via Infotrieve]This article has been cited by other articles:
![]() |
Y. Lampl, J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, et al. Infrared Laser Therapy for Ischemic Stroke: A New Treatment Strategy: Results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1) Stroke, June 1, 2007; 38(6): 1843 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Oron, U. Oron, J. Chen, A. Eilam, C. Zhang, M. Sadeh, Y. Lampl, J. Streeter, L. DeTaboada, and M. Chopp Low-Level Laser Therapy Applied Transcranially to Rats After Induction of Stroke Significantly Reduces Long-Term Neurological Deficits Stroke, October 1, 2006; 37(10): 2620 - 2624. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Lapchak, J. Wei, and J. A. Zivin Transcranial Infrared Laser Therapy Improves Clinical Rating Scores After Embolic Strokes in Rabbits Stroke, August 1, 2004; 35(8): 1985 - 1988. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Tack Insulin Resistance and Acute Cardiovascular Complications Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 85 - 90. [PDF] |
||||
![]() |
L. A. Santana-Blank, E. Rodriguez-Santana, F. Vargas, H. Reyes, P. Fernandez-Andrade, S. Rukos, and K. E. Santana-Rodriguez Phase I Trial of an Infrared Pulsed Laser Device in Patients with Advanced Neoplasias Clin. Cancer Res., October 1, 2002; 8(10): 3082 - 3091. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Shefer, T. A. Partridge, L. Heslop, J. G. Gross, U. Oron, and O. Halevy Low-energy laser irradiation promotes the survival and cell cycle entry of skeletal muscle satellite cells J. Cell Sci., January 4, 2002; 115(7): 1461 - 1469. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |